Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> CANTOR FITZGERALD Latest News

MAR 19, 2013 - Benzinga

A Must Read - Share

UPDATE: Cantor Fitzgerald Lowers PT on Ventrus Biosciences on 4Q Earnings Report

Cantor Fitzgerald analyst Adeyemi Ogunkoya published a report on Ventrus Biosciences (NASDAQ: VTUS) that maintained its Buy rating and lowered the price target from $6 to $5. Cantor Fitzgerald reported that, “The lower-than-expected spending was associated with the closure of the VEN-309 hemorrhoid program.

Tags: UPDATE: Cantor Fitzgerald Lowers PT on Ventrus Biosciences on 4Q Earnings Report,  Cantor Fitzgerald Latest News